Medical and procedural treatment of androgenetic alopecia - Where are we?

Ly, Nathalie Y; Fruechte, Sophia; Hordinsky, Maria K; Sadick, Neil; Arruda, Suleima; Farah, Ronda S

Ly, Nathalie Y; Fruechte, Sophia; Hordinsky, Maria K; Sadick, Neil; Arruda, Suleima; Farah, Ronda S.

Afiliación

Ly NY; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Ohio State University College of Medicine, Columbus, Ohio.
Fruechte S; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Des Moines University College of Osteopathic Medicine, Des Moines, Iowa.
Hordinsky MK; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota.
Sadick N; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Weill Cornell Medical College, New York, New York; Sadick Dermatology, New York, New York.
Arruda S; Sadick Dermatology, New York, New York.
Farah RS; Department of Dermatology, University of Minnesota, Minneapolis, Minnesota; Department of Dermatology, Minneapolis Veterans Affairs Health Care System, Minneapolis, Minnesota. Electronic address: rfarah@umn.edu.

J Am Acad Dermatol ; 89(2S): S36-S39, 2023 08.

Article en En | MEDLINE | ID: mdl-37591565

RESUMEN

Novel medical and procedural options for androgenetic alopecia have arrived. Low-dose oral minoxidil has made its clinical debut, while data on spironolactone, finasteride, and nutritional supplements have advanced. Minimally invasive technological advancements include photobiomodulation and platelet-rich plasma. Within hair transplantation, follicular unit extraction and robotics are now at the clinicians' fingertips.

Asunto(s)

Alopecia; Finasterida; Humanos; Alopecia/tratamiento farmacológico; Finasterida/uso terapéutico; Terapia Conductista; Minoxidil/uso terapéutico; Suplementos Dietéticos

Palabras clave

androgenetic alopecia; finasteride; hair loss; hair transplantation; minoxidil; platelet-rich plasma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Finasterida / Alopecia Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article